New pill takes on tough blood cancers in early human trial
NCT ID NCT04775745
First seen Feb 22, 2026 · Last updated Jun 15, 2026 · Updated 17 times
Summary
This early-stage study tests an experimental oral drug, LP-168, in about 60 people with certain blood cancers (like CLL, lymphoma) that have returned or not responded to prior treatments. The main goals are to find the safest dose and understand how the drug works in the body. Researchers will also look for signs that the drug shrinks tumors or slows the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Duke Univerisity
RECRUITINGDurham, North Carolina, 27708, United States
-
Huntsman Cancer Institute, University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45221, United States
Conditions
Explore the condition pages connected to this study.